1,5-diphenyl-3-benzylamino-1,5-dihydro pyrrolidin-2-one as CB1 receptor modulators

Details for Australian Patent Application No. 2007329808 (hide)

Owner Eli Lilly and Company

Inventors Krushinski, Joseph Herman Junior; Schaus, John Mehnert; Coffey, David Scott; Hu, Jingdan; Tupper, David Edward; Keding, Stacy Jo

Agent Spruson & Ferguson

Pub. Number AU-A-2007329808

PCT Pub. Number WO2008/070306

Priority 60/862,540 23.10.06 US

Filing date 22 October 2007

Wipo publication date 12 June 2008

International Classifications

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

9 April 2009 PCT application entered the National Phase

  PCT publication WO2008/070306 Priority application(s): WO2008/070306

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007329839-Auxiliary peripheral for alerting a computer of an incoming call

2007329807-1, 5-diphenyl-3-pyridinylamino-1, 5-dihydropyrrolidin-2-one as CBL' receptor modulator